The global respiratory syncytial virus respiratory syncytial virus treatment market is undergoing rapid growth, driven by rising vaccine uptake, impr ...

MPV tends to hit hardest in young children, older adults and people with weakened immune systems. A virologist explains.

A major bottleneck in curing HIV (human immunodeficiency virus) is that the virus can hide in an inactive form within resting ...